CDK1 and breast carcinoma: Mechanistically, SL4 induced G2/M arrest in breast cancer cells by activating the MAPK/p21 signaling axis, which subsequently regulated the activity of the CDK1/cyclin A2 and CDK1/cyclin B1 complexes (see Fig. 8C).